|
Twist Bioscience
bispecific t cell engager tce expression plasmid Bispecific T Cell Engager Tce Expression Plasmid, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bispecific+tces/expression+plasmid/bio_rxiv__64898__2026__03__04__709551-252-14-21 Average 86 stars, based on 1 article reviews
bispecific t cell engager tce expression plasmid - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Paratopes
bispecific tces Bispecific Tces, supplied by Paratopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bispecific+tces/bispecific+antibodies/pmc12146755-12-10-26 Average 90 stars, based on 1 article reviews
bispecific tces - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Amunix Inc
bispecific t-cell engager (tce) fusion protein Bispecific T Cell Engager (Tce) Fusion Protein, supplied by Amunix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bispecific+tces/bispecific+t+cell+engager++tce++fusion+protein/pm39663567-203-9-3 Average 90 stars, based on 1 article reviews
bispecific t-cell engager (tce) fusion protein - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
San Miguel Corporation
t-cell engaging (tce) bispecific antibodies T Cell Engaging (Tce) Bispecific Antibodies, supplied by San Miguel Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bispecific+tces/t+cell+engaging++tce++bispecific+antibodies/pm39549892-237-10-31 Average 90 stars, based on 1 article reviews
t-cell engaging (tce) bispecific antibodies - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
BioAtla Inc
dual conditionally activated bispecific (cab) tce against epcam ![]() Dual Conditionally Activated Bispecific (Cab) Tce Against Epcam, supplied by BioAtla Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bispecific+tces/dual+conditionally+activated+bispecific++cab++tce+against+epcam/pmc11599190-190-36-3 Average 90 stars, based on 1 article reviews
dual conditionally activated bispecific (cab) tce against epcam - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Johns Hopkins HealthCare
tce bispecific ![]() Tce Bispecific, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bispecific+tces/bispecific+antibodies/pmc11592057-8-2-7 Average 90 stars, based on 1 article reviews
tce bispecific - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genentech inc
mage-a4/a2, tce bispecific ![]() Mage A4/A2, Tce Bispecific, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bispecific+tces/imc+c103c+mage+a4+hla+a+++02+01+%C3%97+cd3/pmc11592057-4-2-8 Average 90 stars, based on 1 article reviews
mage-a4/a2, tce bispecific - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Wolters Kluwer Health
bispecific tce molecule tarlatamab ![]() Bispecific Tce Molecule Tarlatamab, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bispecific+tces/bispecific+molecule+tarlatamab+tce/10__1097_slash_cco__0000000000001005-51-10-22 Average 86 stars, based on 1 article reviews
bispecific tce molecule tarlatamab - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
Journal: Frontiers in Immunology
Article Title: Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies
doi: 10.3389/fimmu.2024.1490911
Figure Lengend Snippet: Architectures for OR and AND-gate bispecific CARs. (A) OR gates can respond to both TAAs either singly or together, offering an opportunity to restrict antigen escape. Two variations are shown; dual CARs which can be encoded from the same bicistronic vector, or delivered by two separate vectors, allow the use of complementary costimulation domains as shown here. Tandem CARs contain binding domains targeting two distinct antigens within the same CAR. (B) A true AND gate is only activated when both targets are present, and do not respond to cells expressing only one target. The split CAR concept places the domains that drive signal 1 (activation via the CD3z ITAM) and signal 2 (costimulation, shown here with the CD28 ITAM) on separate CARs. A more recent, and potentially more tightly controlled format are the LINK CARs, which place two effectors that lie downstream of the TCR (LAT and SLP76), on two distinct CARs, thus splitting signal 1 in two and requiring engagement of both CARs to initiate T-cell activation. Created with BioRender.com .
Article Snippet: A company called
Techniques: Plasmid Preparation, Binding Assay, Expressing, Activation Assay
Journal: Cancers
Article Title: Unlocking Intracellular Oncology Targets: The Unique Role of Antibody-Based T-Cell Receptor Mimic (TCRm) Therapeutics in T-Cell Engagers (TCEs) and Antibody-Drug Conjugates (ADCs)
doi: 10.3390/cancers16223776
Figure Lengend Snippet: List of recent TCRm therapeutics in preclinical and clinical development.
Article Snippet: HIV/A2 ,
Techniques:
Journal: Cancers
Article Title: Unlocking Intracellular Oncology Targets: The Unique Role of Antibody-Based T-Cell Receptor Mimic (TCRm) Therapeutics in T-Cell Engagers (TCEs) and Antibody-Drug Conjugates (ADCs)
doi: 10.3390/cancers16223776
Figure Lengend Snippet: List of recent TCRm therapeutics in preclinical and clinical development.
Article Snippet: MAGE-A4/A2 ,
Techniques: